Stock Events

Stock Events

UroGen Pharma (URGN) Q4 2025 Earnings

6NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-1.05

-0.93

-0.81

-0.69

Details

Expected EPS

-0.692338

Actual EPS

-0.69

Surprise EPS

0

Surprise Percent

+0.34%

Description

UroGen Pharma (URGN) has reported earnings of -0.69 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.